http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2464993-C1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_93f9324fd04699bcd9e2f46cc4b356df |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-60 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00 |
filingDate | 2011-11-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2012-10-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3540bb9b4b44e30ccab010227832741e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a0463c10988edabfed9dba9de322d0a3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b64bafbdcff2e09bdc46188813f5ee49 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_40cd911d34b5e90db2dec695b39fddc5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b1e249395ff37ed4afd9882e2a101c34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3b23297bec3a9b5a53c7d01d6bcc81cd http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6e59c21c61b3eeeae5241bd92da85f8f |
publicationDate | 2012-10-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | RU-2464993-C1 |
titleOfInvention | Pharmaceutical composition possessing anti-inflammatory, immunotropic, antiallergic and wound healing action |
abstract | FIELD: medicine, pharmaceutics. n SUBSTANCE: invention refers to chemical-pharmaceutical industry, medicine and veterinary science, particularly new drugs for inflammatory diseases of various geneses. What is presented is a pharmaceutical composition possessing anti-inflammatory, immunotropic, antiallergic and wound healing action which represents a solution for parenteral application and contains peptides associated with phospholipids prepared from cod liver, a wedding agent, sodium chloride, a preserving agent and water for injections. The composition may additionally contain ethanol in the amount of 1.0-15.0 wt %, an antioxidant in the amount of 0.01-0.5 wt % and a buffer in the amount of 0.1-5.0 wt %. The pharmaceutical composition has no side effects inherent in previously known drugs used for the same application. n EFFECT: use allows eliminating the application of steroid and non-steroid anti-inflammatory drugs or reducing the doses substantially. n 8 cl, 15 ex, 7 tbl, 1 dwg |
isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2791993-C2 |
priorityDate | 2011-11-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 149.